Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.63 |
| ▸ | GAA | P10253 | 3/20 | 0.63 |
| ▸ | RECQL | P46063 | 2/20 | 0.63 |
| ▸ | DBH | P09172 | 1/20 | 0.63 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.52 |
| ▸ | FUT7 | Q11130 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | SELL | P14151 | 2/20 | 0.52 |
| ▸ | SELP | P16109 | 2/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | CA3 | P07451 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | FUT4 | P22083 | 1/20 | 0.52 |
| ▸ | CA4 | P22748 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17718140 | 0.87 | KDM4E (0.55) | KDM4EGAARECQLDBHFFAR1 | |
| SCHEMBL15631135 | 0.87 | KDM4E (0.55) | KDM4EGAARECQLDBHFFAR1 | |
| SCHEMBL22889639 | 0.86 | GAA (0.53) | KDM4EGAARECQLDBHFFAR1 | |
| SCHEMBL15631140 | 0.86 | KDM4E (0.53) | KDM4EGAARECQLDBHFFAR1 | |
| SCHEMBL12377739 | 0.84 | KDM4E (0.61) | KDM4EGAARECQLDBHFFAR1 | |
| SCHEMBL14339416 | 0.84 | POLB (0.65) | KDM4EGAARECQLDBHFFAR1 | |
| SCHEMBL14339417 | 0.84 | POLB (0.55) | KDM4EGAARECQLDBHFFAR1 | |
| SCHEMBL22889592 | 0.82 | KDM4E (0.59) | KDM4EGAARECQLDBHFFAR1 | |
| SCHEMBL9962964 | 0.82 | GAA (0.56) | KDM4EGAARECQLDBHFFAR1 | |
| SCHEMBL7374206 | 0.80 | TTR (0.57) | KDM4EGAARECQLDBHLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230346864-A1 | Compositions and Methods for Joint Health | INNOPHOS, LLC (US) | 2023-11-02 | — | — | US | disclosed |
| US-20230346864-A1 | Compositions and Methods for Joint Health | INNOPHOS, LLC (US) | 2023-11-02 | — | — | US | disclosed |
| US-11793823-B2 | Compounds and pharmaceutical uses thereof | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2023-10-24 | — | — | US | disclosed |
| US-11779561-B2 | Compounds and pharmaceutical uses thereof | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2023-10-10 | — | — | US | disclosed |
| US-11779561-B2 | Compounds and pharmaceutical uses thereof | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2023-10-10 | — | — | US | disclosed |
| US-20230119068-A1 | METHODS FOR RAPID SYNTHESIS OF PYRANOANTHOCYANINS | OHIO STATE INNOVATION FOUNDATION | 2023-04-20 | — | — | US | disclosed |
| US-20220388968-A1 | INHIBITORS OF ERYTHROCYTE BAND 3 TYROSINE PHOSPHORYLATION AND USES THEREOF | PURDUE RESEARCH FOUNDATION | 2022-12-08 | — | — | US | disclosed |
| US-11382924-B2 | Compounds and pharmaceutical uses thereof | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2022-07-12 | — | — | US | disclosed |
| US-11358985-B2 | Tripeptide compound, preparation method therefor, and application thereof | NORTHWEST UNIVERSITY (CN) | 2022-06-14 | — | — | US | disclosed |
| US-20220152069-A1 | COMPOUNDS AND PHARMACEUTICAL USES THEREOF | SYNEURX INTERNATIONAL (TAIWAN) CORP. (TW) | 2022-05-19 | — | — | US | disclosed |
| US-20130143925-A1 | ACYL PIPERIDINE INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2013-06-06 | — | — | US | disclosed |
| US-8367677-B2 | Comprising trihydroxy phenyl subunits; selectin inhibitors; side effect reduction; 3-{3-[3-(3,4,5-Trihydroxy-phenyl)-propionylamino]-phenylamino}-benzoic acid | REVOTAR BIOPHARMACEUTICALS AG (DE) | 2013-02-05 | — | — | US | disclosed |
| US-20120121536-A1 | COMPOSITIONS AND METHODS FOR GLUCOSE TRANSPORT INHIBITION | OHIO UNIVERSITY (US) | 2012-05-17 | — | — | US | disclosed |
| US-20120121536-A1 | COMPOSITIONS AND METHODS FOR GLUCOSE TRANSPORT INHIBITION | OHIO UNIVERSITY (US) | 2012-05-17 | — | — | US | disclosed |
| US-20110065662-A1 | Compounds, Compositions, and Methods for Protecting Brain Health in Neurodegenerative Disorders | AMAZENTIS SA (CH) | 2011-03-17 | — | — | US | disclosed |
| US-20110065662-A1 | Compounds, Compositions, and Methods for Protecting Brain Health in Neurodegenerative Disorders | AMAZENTIS SA (CH) | 2011-03-17 | — | — | US | disclosed |
| US-20090062186-A1 | Compounds Binding To P-Selectin | YAMANOUCHI ERUOPE B.V. (NL) | 2009-03-05 | — | — | US | disclosed |
| US-20080249107-A1 | Non-Glycosylated/Non-Glycosidic/Non-Peptidic Small Molecule Psgl-1 Mimetics for the Treatment of Inflammatory Disorders | REVOTAR BIOPHARMACEUTICALS AG (DE) | 2008-10-09 | — | — | US | disclosed |
| US-20070282422-A1 | Medical devices and methods for local delivery of elastin-stabilizing compounds | COOK INCORPORATED | 2007-12-06 | — | — | US | disclosed |
| US-20070282422-A1 | Medical devices and methods for local delivery of elastin-stabilizing compounds | COOK INCORPORATED | 2007-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11358985-B2 | Tripeptide compound, preparation method therefor, and application thereof | VIP, PREP, ACE | KDM4E 4263/4885GAA 923/4885RECQL 4409/4885 |
| US-20090062186-A1 | Compounds Binding To P-Selectin | SELP, SELPLG, SELL | KDM4E 4770/4885GAA 1825/4885RECQL 3108/4885 |
| US-20110065662-A1 | Compounds, Compositions, and Methods for Protecting Brain Health in Neurodegenerative Disorders | HTT, BDNF, PYGB | KDM4E 640/4885GAA 73/4885RECQL 908/4885 |
| US-20120121536-A1 | COMPOSITIONS AND METHODS FOR GLUCOSE TRANSPORT INHIBITION | SLC2A1, SLC2A4, SLC2A3 | KDM4E 2744/4885GAA 515/4885RECQL 4575/4885 |
| US-20130143925-A1 | ACYL PIPERIDINE INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE | EPHX1, FAAH, FAAH2 | KDM4E 921/4885GAA 635/4885RECQL 1665/4885 |
| US-20220152069-A1 | COMPOUNDS AND PHARMACEUTICAL USES THEREOF | ACE, ACE2, FURIN | KDM4E 4466/4885GAA 242/4885RECQL 1538/4885 |
| US-20230346864-A1 | Compositions and Methods for Joint Health | MMP14, MMP13, MMP1 | KDM4E 1693/4885GAA 735/4885RECQL 543/4885 |
| US-20230119068-A1 | METHODS FOR RAPID SYNTHESIS OF PYRANOANTHOCYANINS | HCCS, PPOX, RNGTT | KDM4E 2442/4885GAA 1503/4885RECQL 588/4885 |
| US-20220388968-A1 | INHIBITORS OF ERYTHROCYTE BAND 3 TYROSINE PHOSPHORYLATION AND USES THEREOF | SPTBN1, CTTN, HBG1 | KDM4E 2947/4885GAA 1738/4885RECQL 1377/4885 |
| US-11382924-B2 | Compounds and pharmaceutical uses thereof | ACE, ACE2, FURIN | KDM4E 4466/4885GAA 242/4885RECQL 1538/4885 |
| US-11779561-B2 | Compounds and pharmaceutical uses thereof | ACE, ACE2, FURIN | KDM4E 4466/4885GAA 242/4885RECQL 1538/4885 |
| US-20080249107-A1 | Non-Glycosylated/Non-Glycosidic/Non-Peptidic Small Molecule Psgl-1 Mimetics for the Treatment of Inflammatory Disorders | SELP, SELPLG, SELE | KDM4E 4259/4885GAA 2954/4885RECQL 4093/4885 |
| US-11793823-B2 | Compounds and pharmaceutical uses thereof | HRH4, OR10J3, CYP3A5 | KDM4E 2317/4885GAA 1734/4885RECQL 1033/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.